WHO suggestions need manufacturers to put into action a continuous chance administration approach for sterility test isolators, together with standard risk assessments and the development of hazard-based mostly control tactics. Manufacturers looking to carry out these approaches need to provide sturdy validation facts to display their equivalence to pharmacopoeial waiting for link from Forum Profiles (6)